LODC
CVS icon

Lanham O'Dell & Company’s CVS Health CVS Stock Holding History

Lanham O'Dell & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,009
Closed -$203K – 21
2022
Q1 		$203K Hold
2,009
– – 0.16% 18
2021
Q4 		$207K Buy
+2,009
New +$186K 0.16% 20

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lanham O'Dell & Company's CVS Position: Q2 2022 in Review

Lanham O'Dell & Company sold out of CVS Health (CVS) in Q2 2022, closing a stake of 2,009 shares — an estimated $203K sold.

Lanham O'Dell & Company first reported a position in CVS in Q4 2021 and held it in 2 quarters. The position peaked at $207K in Q4 2021. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Lanham O'Dell & Company reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
  • Lanham O'Dell & Company sold 2,009 CVS Health shares in Q2 2022, an estimated $203K.
  • Lanham O'Dell & Company first reported a position in CVS Health in Q4 2021 and held it in 2 quarters.
  • Lanham O'Dell & Company's CVS Health position peaked at $207K in Q4 2021.
  • 2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Lanham O'Dell & Company's 13F filing for Q2 2022, filed 9 Aug 2022.